MannKind (NASDAQ: MNKD) revenue
MannKind reported revenue of $349.0m for fiscal 2025, 22.2% more than in fiscal 2024 ($285.5m). Since fiscal 2016 its revenue has grown by 99.7%, an average growth of 8.0% a year.
MannKind has grown its revenue for 8 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2017, −93.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $349.0m | +22.2% | $38.8m | 11.1% |
| 2024 | $285.5m | +43.5% | $72.6m | 25.4% |
| 2023 | $199.0m | +99.4% | $8.7m | 4.4% |
| 2022 | $99.8m | +32.2% | −$64.1m | −64.3% |
| 2021 | $75.4m | +15.8% | −$47.0m | −62.3% |
| 2020 | $65.1m | +3.3% | −$47.9m | −73.5% |
| 2019 | $63.0m | +126.3% | −$44.6m | −70.7% |
| 2018 | $27.9m | +137.2% | −$76.6m | −274.9% |
| 2017 | $11.7m | −93.3% | −$108.2m | −921.1% |
| 2016 | $174.8m | — | $67.3m | 38.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
MannKind revenue compared with its sector
By revenue for its latest fiscal year, MannKind ranks 211th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; MannKind, 22.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 209th | Twist Bioscience | $376.6m | 20.3% |
| 210th | Arcutis Biotherapeutics | $376.1m | 91.3% |
| 211th | MannKind | $349.0m | 22.2% |
| 212th | Inogen | $348.7m | 3.9% |
| 213th | Castle Biosciences | $344.2m | 3.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of MannKind
- How much revenue did MannKind make in fiscal 2025?
- MannKind reported revenue of $349.0m for fiscal 2025, compared with $285.5m in fiscal 2024.
- How much has the revenue of MannKind grown?
- Between fiscal 2016 and fiscal 2025 it went from $174.8m to $349.0m: 99.7% more, an average growth of 8.0% a year.
- What was the best year for revenue at MannKind?
- Of its last 10 fiscal years, fiscal 2025, with $349.0m.
- Where does MannKind rank in its sector by revenue?
- It ranks 211th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for MannKind come from?
- From the annual report (Form 10-K) that MannKind files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that MannKind files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on MannKind: the MannKind page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.